The emerging role of low-molecular-weight heparin in cardiovascular medicine
- 29 February 2000
- journal article
- review article
- Published by Elsevier in Progress in Cardiovascular Diseases
- Vol. 42 (4) , 235-246
- https://doi.org/10.1053/pcad.2000.0420235
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- Low-Molecular-Weight HeparinsNew England Journal of Medicine, 1997
- A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Acute Pulmonary EmbolismNew England Journal of Medicine, 1997
- Low-Molecular-Weight Heparin in the Treatment of Patients with Venous ThromboembolismNew England Journal of Medicine, 1997
- Reduction of reinfarction and angina with use of low-molecular-weight heparin therapy after streptokinase (and heparin) in acute myocardial infarctionThe American Journal of Cardiology, 1996
- Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated HeparinNew England Journal of Medicine, 1995
- Comparison of High-Dose with Low-Dose Subcutaneous Heparin to Prevent Left Ventricular Mural Thrombosis in Patients with Acute Transmural Anterior Myocardial InfarctionNew England Journal of Medicine, 1989
- Angiographic demonstration of a common link between unstable angina pectoris and non-Q wave acute myocardial infarctionThe American Journal of Cardiology, 1988
- Continuous Intravenous Heparin Compared with Intermittent Subcutaneous Heparin in the Initial Treatment of Proximal-Vein ThrombosisNew England Journal of Medicine, 1986
- Structure-activity relationship in heparin: A synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activityBiochemical and Biophysical Research Communications, 1983
- Highly active heparin species with multiple binding sites for antithrombinBiochemical and Biophysical Research Communications, 1979